China Resources Double-Crane Pharmaceutical Co.,Ltd. Statistics

Total Valuation

China Resources Double-Crane Pharmaceutical Co.,Ltd. has a market cap or net worth of CNY 21.94 billion. The enterprise value is 20.61 billion.

Market Cap	21.94B
Enterprise Value	20.61B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Jul 15, 2024

Share Statistics

China Resources Double-Crane Pharmaceutical Co.,Ltd. has 1.03 billion shares outstanding. The number of shares has decreased by -0.92% in one year.

Shares Outstanding	1.03B
Shares Change (YoY)	-0.92%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	0.13%
Owned by Institutions (%)	12.01%
Float	399.77M

Valuation Ratios

The trailing PE ratio is 15.70 and the forward PE ratio is 12.16.

PE Ratio	15.70
Forward PE	12.16
PS Ratio	2.12
PB Ratio	2.21
P/FCF Ratio	18.18
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.61, with an EV/FCF ratio of 17.08.

EV / Earnings	14.78
EV / Sales	2.00
EV / EBITDA	9.61
EV / EBIT	14.12
EV / FCF	17.08

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 2.41.

Current Ratio	1.46
Quick Ratio	1.07
Debt / Equity	2.41
Debt / EBITDA	0.12
Debt / FCF	0.21
Interest Coverage	118.66

Financial Efficiency

Return on equity (ROE) is 12.64% and return on invested capital (ROIC) is 8.07%.

Return on Equity (ROE)	12.64%
Return on Assets (ROA)	5.79%
Return on Capital (ROIC)	8.07%
Revenue Per Employee	840,143
Profits Per Employee	113,691
Employee Count	12,269
Asset Turnover	0.66
Inventory Turnover	2.66

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.31% in the last 52 weeks. The beta is 0.09, so China Resources Double-Crane Pharmaceutical Co.,Ltd.'s price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	+33.31%
50-Day Moving Average	19.02
200-Day Moving Average	19.70
Relative Strength Index (RSI)	65.95
Average Volume (20 Days)	12,121,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, China Resources Double-Crane Pharmaceutical Co.,Ltd. had revenue of CNY 10.31 billion and earned 1.39 billion in profits. Earnings per share was 1.36.

Revenue	10.31B
Gross Profit	5.71B
Operating Income	1.45B
Pretax Income	1.60B
Net Income	1.39B
EBITDA	2.11B
EBIT	1.45B
Earnings Per Share (EPS)	1.36

Full Income Statement

Balance Sheet

The company has 2.27 billion in cash and 255.71 million in debt, giving a net cash position of 2.02 billion or 1.97 per share.

Cash & Cash Equivalents	2.27B
Total Debt	255.71M
Net Cash	2.02B
Net Cash Per Share	1.97
Equity (Book Value)	10.62B
Book Value Per Share	9.67
Working Capital	2.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.80 billion and capital expenditures -593.93 million, giving a free cash flow of 1.21 billion.

Operating Cash Flow	1.80B
Capital Expenditures	-593.93M
Free Cash Flow	1.21B
FCF Per Share	1.18

Full Cash Flow Statement

Margins

Gross margin is 55.40%, with operating and profit margins of 14.04% and 13.53%.

Gross Margin	55.40%
Operating Margin	14.04%
Pretax Margin	15.50%
Profit Margin	13.53%
EBITDA Margin	20.43%
EBIT Margin	14.04%
FCF Margin	11.71%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.94%.

Dividend Per Share	0.20
Dividend Yield	0.94%
Dividend Growth (YoY)	-55.54%
Years of Dividend Growth	n/a
Payout Ratio	69.96%
Buyback Yield	0.92%
Shareholder Yield	1.85%
Earnings Yield	6.37%
FCF Yield	5.50%

Dividend Details

Stock Splits

The last stock split was on August 16, 2018. It was a forward split with a ratio of 1.2.

Last Split Date	Aug 16, 2018
Split Type	Forward
Split Ratio	1.2